(19)
(11) EP 4 210 672 A1

(12)

(43) Date of publication:
19.07.2023 Bulletin 2023/29

(21) Application number: 21783349.0

(22) Date of filing: 09.09.2021
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/26(2006.01)
A61K 45/06(2006.01)
A61K 31/00(2006.01)
A61M 15/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0075; A61K 47/26; A61K 31/00; A61M 2202/064; A61M 2209/06; A61P 11/00; A61M 15/0028; A61M 15/002; A61M 15/0031; A61M 2209/02; A61M 11/003; A61M 2205/70; A61K 31/728
 
C-Sets:
A61M 2202/064, A61M 2202/0007;
(86) International application number:
PCT/IB2021/058205
(87) International publication number:
WO 2022/053969 (17.03.2022 Gazette 2022/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.09.2020 IT 202000021361

(71) Applicant: Alfasigma S.p.A.
40133 Bologna (IT)

(72) Inventor:
  • BIFFI, Andrea
    20060 Trezzano Rosa [MI] (IT)

(74) Representative: Benedetto, Marco 
Marben S.r.l. Via Larga, 16
20122 Milano
20122 Milano (IT)

   


(54) HYALURONIC ACID OR SALT THEREOF FOR INHALATION USE IN THE TREATMENT OF RESPIRATORY DISEASES, AND AN INHALER DEVICE CONTAINING THE SAME